All News

More patients are turning to the Internet and mobile applications (apps) with the explosive growth of mobile technology devices.

The public is generally satisfied with cancer research progress over the past 20 years. However, they believe it takes too long for new cancer drugs to reach patients and that their countries invest too little in fighting cancer, according a global survey.

FDA approved mipomersen sodium (Kynamro, Genzyme and Isis Pharmaceuticals) once-a-week injection as an addition to lipid-lowering medications and diet to treat patients with a rare type of high cholesterol called homozygous familial hypercholesterolemia (HoFH).

An FDA advisory committee voted to move hydrocodone combination drugs from Schedule III into the more restrictive Schedule II category of controlled substances in late January.

The cost of managing diabetes patients is extremely high, and many patients still experience poor glycemic control and renal complications, according to results of a study published online Dec. 13, 2012 in the journal Diabetes Care.

The use of clarithromycin in the first trimester of pregnancy may increase the risk of miscarriage, according to researchers in Denmark. However, the researchers did not find a link between exposure to clarithromycin and major congenital malformations.

Social ties to industry appear to influence physician prescribing behaviors, according to a recent study published online January 7 in JAMA Internal Medicine (formerly Archives of Internal Medicine).

Researchers examining the effectiveness of cefixime in the treatment of gonorrhea found a relatively high treatment failure rate, raising concern that gonorrhea may become untreatable, according to results published Jan. 9 in the Journal of the American Medical Association.